EcoPhage, a leader in the development of sustainable phage-based biopesticides for the control of bacterial plant diseases, announced that it has entered into a non-exclusive distribution agreement with CNI AG for the marketing and sales of its innovative biological product, GoldenEco®, in the United States.
The agreement represents an important milestone in EcoPhage’s commercial expansion in the U.S. market and brings together EcoPhage’s proprietary phage-based technology platform with CNI AG’s extensive distribution network and strong relationships with independent agricultural retailers across the country.
GoldenEco® is a phage-based biological product developed to address bacterial diseases affecting tomatoes and peppers, including diseases caused by Xanthomonas and Pseudomonas species. EcoPhage submitted GoldenEco® to the U.S. Environmental Protection Agency (EPA) in late 2023 and currently expects regulatory approval later this year.
A New Approach to Bacterial Disease Management
Bacterial diseases remain a significant challenge for growers, while disease-management programs have historically relied heavily on copper-based products. The emergence of resistance, concerns regarding environmental and chemical footprints, and evolving regulatory requirements are increasing the demand for innovative and more sustainable solutions.
EcoPhage’s proprietary research and development platform is designed to identify, develop, and optimize phage-based solutions targeting bacterial plant pathogens across multiple crops. The platform supports the development of natural, non-GMO and zero-residue biological products, with the potential to provide effective disease management while supporting more sustainable agricultural practices.
Expanding Access to Biological Solutions for U.S. Growers
CNI AG, founded in 1974 by independent agricultural business owners, is a nationwide wholesale distributor supplying crop protection products, fertilizers, and seeds to independent agricultural retailers. CNI AG operates 24 distribution centers across 40 states and serves more than 600 independent agricultural retailers.
Through this partnership, EcoPhage and CNI AG will work together to introduce GoldenEco® to the U.S. agricultural market and provide growers with access to EcoPhage’s new biological approach to bacterial disease management.
